Regeneron Pharmaceuticals
REGN
$914.36
Share price
0.78%
Change (1 day)
14.72%
Change (1 year)
Categories
Regeneron Pharmaceuticals (REGN) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $7.10 B
According to Regeneron Pharmaceuticals's latest financial reports the company's total liabilities are $7.10 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Regeneron Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $7.10 B | 8.5% |
| 2022-12-31 | $6.55 B | -1.73% |
| 2021-12-31 | $6.66 B | 8.6% |
| 2020-12-31 | $6.13 B | 65.2% |
| 2019-12-31 | $3.71 B | 24.8% |
| 2018-12-31 | $2.97 B | 13.62% |
| 2017-12-31 | $2.62 B | 3.8% |
| 2016-12-31 | $2.52 B | 29.16% |
| 2015-12-31 | $1.95 B | 51.8% |
| 2014-12-31 | $1.28 B | 28.88% |
| 2013-12-31 | $0.99 B | 19.62% |
| 2012-12-31 | $0.83 B | -0.33% |
| 2011-12-31 | $0.83 B | 49.19% |
| 2010-12-31 | $0.56 B | 63.05% |
| 2009-12-31 | $0.34 B | 13.79% |
| 2008-12-31 | $0.30 B | -36.41% |
| 2007-12-31 | $0.47 B | 29.18% |
| 2006-12-31 | $0.36 B | 19.05% |
| 2005-12-31 | $0.30 B | 6.52% |
| 2004-12-31 | $0.29 B | -15.02% |
| 2003-12-31 | $0.34 B | 39.22% |
| 2002-12-31 | $0.24 B | 7.23% |
| 2001-12-31 | $0.22 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 1,289.93% | 🇺🇸 USA |
 Novartis NVS | $53.19 B | 648.48% | 🇨🇭 Switzerland |
 Amgen AMGN | $90.92 B | 1,179.31% | 🇺🇸 USA |
 Sanofi SNY | $57.61 B | 710.64% | 🇫🇷 France |
 Biogen BIIB | $12.04 B | 69.48% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $4.05 B | -43.01% | 🇺🇸 USA |